Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Lisa M Rimsza

1PUBLICATIONS

15CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Jul 08, 2022

Next-generation ALK inhibitors are highly active in ALK-positive large B-cell lymphoma.

Jacob D Soumerai, Allison Rosenthal, Shannon Harkins

Pageof 1

Frequent Collaborators

1 joint publications

Jacob D Soumerai

1 joint publications

Shannon Harkins

1 joint publications

Jessica Duffy

1 joint publications

Carmen Mecca

1 joint publications

Cedric Menard

1 joint publications

Ahmet Dogan

1 joint publications

Lei Yang

1 joint publications

Matthew Lei

1 joint publications

Anna Kurilovich

1 joint publications

Olga Kudryashova

Frequent Collaborators

1 joint publications

Jacob D Soumerai

1 joint publications

Shannon Harkins

1 joint publications

Jessica Duffy

1 joint publications

Carmen Mecca

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

See more related videos

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

See more related videos